D-dimer, a biomarker for detecting severity of SARS-CoV2: a systematic review


  • Shreyans D. Singhvi Department of Medicine, Manidhari Hospital, Jodhpur, Rajasthan, India
  • Preksha T. Singh Department of Medicine, Manidhari Hospital, Jodhpur, Rajasthan, India
  • Gautam Bhandari Department of Medicine, Manidhari Hospital, Jodhpur, Rajasthan, India
  • Rafe M. Khan Department of Medicine, Sardar Vallabhbhai Institute of Medical Sciences and Research, Gujarat, Ahmedabad, India




D-dimer, SARS-CoV2, Biomarker


A global pandemic of the novel corona virus has impacted the world on severe terms. Not only it has raised an impact on the health care systems as well as the economic and mental health of individuals. SARS-CoV-2 (severe acute respiratory virus- corona virus 2), the outbreak is associated to have likely started as a zoonotic transmission with a seafood market, it has now become clear of the person to person transmission of it. Currently, the virus has been called a global pandemic and has infected 8.72 million people worldwide (dated 21st June 2020). Since, the pandemic has affected multiple countries, our aim of the study is to study d-dimer a biomarker, that may reflect severity of the cases affected by the virus. The search was done based on preferred reporting system for meta-analysis and systemic review (PRISMA) guideline. All the scientific database like Pubmed central, NIH, NCBI, embrase, mediline, Cochrane and google scholar were used to research articles with keywords: ‘d-dimer, ‘SARS-CoV2’, ’severe cases’. All the published peer reviewed articles till date 17th June 2020 were studied. 9 articles were selected in the review and they depicted a higher value of d-dimer can be related to severity of the case of SARS-CoV2. Our study concludes that, for early severe case detection, an early detection of d-dimer levels can be done and treatment to reduce the value in the early cases may provide intervention to the prognosis of the disease. As, the number of cases leading to a severe case and requiring an ICU facility will decline, the mortality rate might drastically decline as well as earlier screening of a severe case of SARS-CoV-2 would help in faster intervention for the same.


Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382:1199-207.

Turner AJ, Hiscox JA, Hooper NM. ACE2: from vasopeptidase to SARS virus receptor. Trends Pharmacol Sci. 2004;25:291-4.

Alhogbani T. Acute myocarditis associated with novel middle east respiratory syndrome coronavirus. Ann. Saudi Med. 2016;36:78-80.

Zheng Y, Ma Y, Zhang J, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17:259-60.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506.

Giamarellos-Bourboulis EJ, Netea MG, Rovina N, Akinosoglou K, Antoniadou A, Antonakos N, et al. Complex immune dysregulation in COVID-19 patients with severe respiratory failure. Cell Host Microbe. 2020;27:1-9.

Leonard-Lorant I, Delabranche X, Severac F, Helms J, Pauzet C, Collange O, et al. Acute pulmonary embolism in COVID-19 patients on CT angiography and relationship to D-dimer levels. Radiol. 2020:201561.

Zhang L, Yan X, Fan Q, Liu H, Liu X, Liu Z, et al. D‐dimer levels on admission to predict in‐hospital mortality in patients with Covid‐19. J Thrombo Haemo. 2020;18(6):1324-9.

Gao, Y, Li, T, Han, M, Li X, Wu D, Xu Y, et al. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID‐19. J Med Virol. 2020;92:791-6.

Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thrombo Haemos. 2020;18(4):844-7.

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-9.

Wu C, Chen X, Cai Y, Zhou X, Xu S, Huang H, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020;1:E1-E10.

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(0229):1054-62.

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507‐13.

de Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016;14(8):523‐34.






Review Articles